ArticleClinicoEconomics and outcomes research : CEOR2026
Cost-Effectiveness of Bivalent Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Italy.
Sergio Di Matteo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.